HealthInvest Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CFN
CAREFUSION CORPORATION
CFN
|
+$8.48M |
| 2 |
MGLN
Magellan Health Services, Inc.
MGLN
|
+$8.36M |
| 3 |
Cardinal Health
CAH
|
+$8.25M |
| 4 |
AET
Aetna Inc
AET
|
+$7.85M |
| 5 |
GTS
Triple-S Management Corporation
GTS
|
+$6.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Myriad Genetics
MYGN
|
+$7.93M |
| 2 |
McKesson
MCK
|
+$6.79M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
+$4.58M |
| 4 |
BCR
CR Bard Inc.
BCR
|
+$2.95M |
| 5 |
CUTR
Cutera, Inc.
CUTR
|
+$877K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 86.08% |
| 2 | Financials | 10% |
| 3 | Miscellaneous | 3.91% |
Similar funds
HealthInvest Partners's Q1 2014 Portfolio in Review
As of Q1 2014, HealthInvest Partners held 23 positions worth $140M, up 40% from $101M the previous quarter. Its ten largest holdings account for 73% of the portfolio.
HealthInvest Partners deployed $33.4M of net new capital in Q1 2014, opening 5 new positions and adding to 9 existing holdings. Its largest new stake was CAREFUSION CORPORATION: 209,600 shares worth $8.43M.
By sector, the portfolio is most concentrated in Healthcare at 86% of assets, down from 96% a quarter earlier, followed by Financials and Miscellaneous.
On the sell side, the largest reduction was Express Scripts Holding Company, an estimated $4.58M trimmed.
- HealthInvest Partners's largest Q1 2014 buy was CAREFUSION CORPORATION: 209,600 shares worth $8.43M.
- HealthInvest Partners added most to Hologic in Q1 2014, an estimated $5.44M increase.
- HealthInvest Partners's biggest Q1 2014 reduction was Express Scripts Holding Company, cutting an estimated $4.58M.
- HealthInvest Partners fully exited Myriad Genetics in Q1 2014, selling an estimated $7.93M.
- HealthInvest Partners's ten largest holdings make up 73% of its $140M portfolio in Q1 2014.
- HealthInvest Partners opened 5 new positions and closed 5 in Q1 2014.
- HealthInvest Partners's portfolio value rose 40% quarter-over-quarter to $140M.
Based on HealthInvest Partners's 13F filing for Q1 2014, filed 23 Apr 2014.